• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    3.325 -0.065 (-1.92%)
    Streaming Delayed Price Updated: 10:33 AM EDT, Apr 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,659,387
    Open 3.330
    Bid (Size) 3.320 (9,400)
    Ask (Size) 3.330 (11,700)
    Prev. Close 3.390
    Today's Range 3.270 - 3.340
    52wk Range 2.800 - 7.180
    Shares Outstanding 168,425,907
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
    In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a... 
    Via MarketMinute
    Topics Artificial Intelligence

    Performance

    YTD
    -20.8%
    -20.8%
    1 Month
    -5.3%
    -5.3%
    3 Month
    -31.6%
    -31.6%
    6 Month
    -45.4%
    -45.4%
    1 Year
    -16.2%
    -16.2%

    More News

    Read More
    News headline image
    1 Beaten-Down AI Stock to Buy and 1 to Avoid ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    Recursion Pharmaceuticals (NASDAQ:RXRX) Soars on Q4 Earnings Beat ↗
    Via Chartmill
    News headline image
    Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
    From Citeline
    Via GlobeNewswire
    News headline image
    2 AI Healthcare Stocks to Buy Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Prediction: The "Trough of Disillusionment" Will Create the Best Buying Opportunity for Artificial Intelligence (AI) Stocks in 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Can This AI Stock Bounce Back in 2026? ↗
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    News headline image
    Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Recursion (RXRX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence Earnings
    News headline image
    What's Behind The Jump In Recursion Pharmaceuticals Stock? ↗
    Via Benzinga
    News headline image
    RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Recursion Pharmaceuticals Stock Drops: What's Behind It? ↗
    Via Benzinga
    News headline image
    Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    The Biotechnology Renaissance: AI and Capital Collide in a Multi-Trillion Dollar Pivot
    Via MarketMinute
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    This $4 Stock Could Be Your Ticket to Millionaire Status ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Harvard’s PopEVE AI Cracks the Code of Rare Diseases: Ending the ‘Diagnostic Odyssey’ for Millions
    Via TokenRing AI
    Topics Artificial Intelligence

    Frequently Asked Questions

    Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
    What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.325
    When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 04/09/26 10:33 AM ET
    What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 560.02M
    How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock has 560M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.